These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3950901)

  • 1. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 2. Structural modification of 7-(substituted aryl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives.
    Hoffman WF; Alberts AW; Cragoe EJ; Deana AA; Evans BE; Gilfillan JL; Gould NP; Huff JW; Novello FC; Prugh JD
    J Med Chem; 1986 Feb; 29(2):159-69. PubMed ID: 3950901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 3. 7-(3,5-Disubstituted [1,1'-biphenyl]-2-yl)-3,5-dihydroxy-6-heptenoic acids and their lactone derivatives.
    Stokker GE; Alberts AW; Anderson PS; Cragoe EJ; Deana AA; Gilfillan JL; Hirshfield J; Holtz WJ; Hoffman WF; Huff JW
    J Med Chem; 1986 Feb; 29(2):170-81. PubMed ID: 3950902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 1. Lactones of pyridine- and pyrimidine-substituted 3,5-dihydroxy-6-heptenoic (-heptanoic) acids.
    Beck G; Kesseler K; Baader E; Bartmann W; Bergmann A; Granzer E; Jendralla H; von Kerekjarto B; Krause R; Paulus E
    J Med Chem; 1990 Jan; 33(1):52-60. PubMed ID: 2296036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 6. Trans-6-[2-(substituted-1-naphthyl)ethyl(or ethenyl)]-3,4,5,6-tetrahydro-4-hydroxy-2H-pyran-2-ones.
    Prugh JD; Alberts AW; Deana AA; Gilfillian JL; Huff JW; Smith RL; Wiggins JM
    J Med Chem; 1990 Feb; 33(2):758-65. PubMed ID: 2299642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. QSAR study of HMGR inhibitors: 7-(heteroaryl)-3,5-dihydroxy-6-heptenoic (-heptanoic) acids.
    Prabhakar YS
    Drug Des Discov; 1992; 9(2):145-54. PubMed ID: 1296797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 1. Structural modification of 5-substituted 3,5-dihydroxypentanoic acids and their lactone derivatives.
    Stokker GE; Hoffman WF; Alberts AW; Cragoe EJ; Deana AA; Gilfillan JL; Huff JW; Novello FC; Prugh JD; Smith RL
    J Med Chem; 1985 Mar; 28(3):347-58. PubMed ID: 3973903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 5. 6-(Fluoren-9-yl)- and 6-(fluoren-9-ylidenyl)-3,5-dihydroxyhexanoic acids and their lactone derivatives.
    Stokker GE; Alberts AW; Gilfillan JL; Huff JW; Smith RL
    J Med Chem; 1986 May; 29(5):852-5. PubMed ID: 3701793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis of arylnaphthalenyl derivatives: inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme a reductase.
    Mewshaw RE; Hild EK; Commons TJ; Strike DP
    Drug Des Deliv; 1988 Nov; 3(3):235-43. PubMed ID: 3255330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of cholesterol biosynthesis. 3. Tetrahydro-4-hydroxy-6-[2-(1H-pyrrol-1-yl)ethyl]-2H-pyran-2-one inhibitors of HMG-CoA reductase. 2. Effects of introducing substituents at positions three and four of the pyrrole nucleus.
    Roth BD; Blankley CJ; Chucholowski AW; Ferguson E; Hoefle ML; Ortwine DF; Newton RS; Sekerke CS; Sliskovic DR; Stratton CD
    J Med Chem; 1991 Jan; 34(1):357-66. PubMed ID: 1992137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mode of interaction of beta-hydroxy-beta-methylglutaryl coenzyme A reductase with strong binding inhibitors: compactin and related compounds.
    Nakamura CE; Abeles RH
    Biochemistry; 1985 Mar; 24(6):1364-76. PubMed ID: 3886005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of new HMG-CoA reductase inhibitors. 2. Derivatives of 7-(1H-pyrrol-3-yl)-substituted-3,5-dihydroxyhept-6(E)-enoic (-heptanoic) acids.
    Jendralla H; Baader E; Bartmann W; Beck G; Bergmann A; Granzer E; von Kerekjarto B; Kesseler K; Krause R; Schubert W
    J Med Chem; 1990 Jan; 33(1):61-70. PubMed ID: 2153213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study of the role of hydrophobicity in the activity of HMGR inhibitors.
    Prabhakar YS; Saxena AK; Doss MJ
    Drug Des Deliv; 1989 Mar; 4(2):97-108. PubMed ID: 2765111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 7-(Disubstituted thiazolyl)-3,5-dihydroxy-6-heptenoic/heptanoic acid derivatives as HMG-CoA reductase inhibitors.
    Cecchetti V; Fravolini A; Pagella PG; Tabarrini O; Temperini A
    Bioorg Med Chem; 1994 Aug; 2(8):799-806. PubMed ID: 7894974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of cholesterol biosynthesis. 4. trans-6-[2-(substituted-quinolinyl)ethenyl/ethyl]tetrahydro-4-hydroxy-2 H-pyran-2-ones, a novel series of HMG-CoA reductase inhibitors.
    Sliskovic DR; Picard JA; Roark WH; Roth BD; Ferguson E; Krause BR; Newton RS; Sekerke C; Shaw MK
    J Med Chem; 1991 Jan; 34(1):367-73. PubMed ID: 1992138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin.
    Hoffman WF; Alberts AW; Anderson PS; Chen JS; Smith RL; Willard AK
    J Med Chem; 1986 May; 29(5):849-52. PubMed ID: 3634830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbial conversion of mevinolin.
    Jekkel A; Kónya A; Ilkóy E; Boros S; Horváth G; Sütó J
    J Antibiot (Tokyo); 1997 Sep; 50(9):750-4. PubMed ID: 9360620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological profile, and quantitative structure-activity relationship of a series of novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Sit SY; Parker RA; Motoc I; Han W; Balasubramanian N; Catt JD; Brown PJ; Harte WE; Thompson MD; Wright JJ
    J Med Chem; 1990 Nov; 33(11):2982-99. PubMed ID: 2231596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-selective inhibition of cholesterol synthesis in vivo by pravastatin sodium, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor.
    Koga T; Shimada Y; Kuroda M; Tsujita Y; Hasegawa K; Yamazaki M
    Biochim Biophys Acta; 1990 Jul; 1045(2):115-20. PubMed ID: 2116173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HMG-CoA reductase inhibitors: design, synthesis, and biological activity of tetrahydroindazole-substituted 3,5-dihydroxy-6-heptenoic acid sodium salts.
    Connolly PJ; Westin CD; Loughney DA; Minor LK
    J Med Chem; 1993 Nov; 36(23):3674-85. PubMed ID: 8246237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of rat brain prostaglandin D synthase by 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors.
    Islam F; Watanabe Y; Hayaishi O
    Biochem Int; 1990 Nov; 22(4):601-5. PubMed ID: 2127671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.